Cencora, Inc. (COR)
NYSE
Closed
Aug 21, 2026
Day's Range
313.1352 wk Range
244.82Overview - COR - Cencora, Inc.
Key Statistics
Valuation
Enterprise Value
71.88B
P/E (Trailing)
‪23.66‬
P/E (Forward)
‪16.11‬
PEG Ratio
‪2.10‬
Price / Sales (TTM)
‪0.18‬
Price / Book
‪19.94‬
EV / EBITDA
‪12.96‬
Profitability
Gross Margin
‪4.25%‬
Profit Margin
‪0.78%‬
Operating Margin
‪1.41%‬
Return on Assets
‪3.55%‬
Return on Equity
‪96.87%‬
Ownership
Shares Outstanding
190.82M
Float
180.23M
Short % of Shares Outstanding
‪3.08%‬
Held by Insiders
‪4.30%‬
Held by Institutions
‪99.59%‬
Price stats
Beta
‪0.57‬
50-Day Avg
‪301.70‬
200-Day Avg
‪323.65‬
Dividends
Payout Ratio
‪17.45%‬
Frequency
Quarterly
Analyst Consensus
15 analysts
Average price target
‪$ 369.31‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - COR - Cencora, Inc.
Peers - COR - Cencora, Inc.
Peer Comparison
Compared with companies in Medical Distribution listed on NYSE.
Profile Summary - COR - Cencora, Inc.
About
Cencora, Inc. is a leading global pharmaceutical solutions organization that distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment to healthcare providers worldwide. It serves acute care hospitals, health systems, independent and chain retail pharmacies, mail-order…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
